# Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects

> **NCT02176252** · PHASE1 · COMPLETED · sponsor: **Ardelyx** · enrollment: 83 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** AZD1722
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02176252
- **Lead sponsor:** Ardelyx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2014-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02176252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02176252, "Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02176252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*